Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Ciclosporin (inhalation use)

EU orphan designation number: EU/3/04/210   
Active ingredient: Ciclosporin (inhalation use)
Indication: Treatment of graft rejection after lung transplantation
Sponsor: PARI Pharma GmbH
Moosstrasse 3, D-82319 Starnberg, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
02/08/2004 Centralised Orphan - Designation EMEA/OD/022/04 (2004)2997 of 29/07/2004
12/10/2007 Other procedure
05/11/2010 Other procedure EMA/367444/2010
30/05/2011 Other procedure EMEA/OD/022/04